Point72 Asset Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43,211
Closed -$2.54M 2084
2024
Q1
$2.54M Buy
+43,211
New +$1.86M 0.01% 1184
2023
Q4
Sell
-527
Closed -$7.95K 2391
2023
Q3
$11.4K Buy
+527
New +$20.7K ﹤0.01% 2327
2023
Q2
Sell
-137,057
Closed -$56.7M 2410
2023
Q1
$63.9M Sell
137,057
-54,209
-28% -$28.7M 0.23% 127
2022
Q4
$76.6M Buy
191,266
+158
+0.1% +$60.5K 0.29% 97
2022
Q3
$62.2M Sell
191,108
-11,544
-6% -$3.72M 0.27% 104
2022
Q2
$53.5M Sell
202,652
-30,634
-13% -$7.83M 0.25% 115
2022
Q1
$70.1M Buy
233,286
+83,982
+56% +$29.3M 0.31% 91
2021
Q4
$52.6M Buy
149,304
+104,860
+236% +$32.6M 0.23% 127
2021
Q3
$11.4M Buy
+44,444
New +$15.7M 0.05% 455

Other funds holding KYNB